Sodium Chloride · SODIUM CHLORIDE 900 mg/100mL · Injection · Intravenous · Fresenius Medical Care de Mexico, S.A. de C.V.
NDC 46163-0300-10 · 12 BAG in 1 CARTON / 1000 mL in 1 BAG · ANDA · View full market →
11 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 1.5% of the time — roughly 10× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Matched to CMS's representative package for this drug (NDC 00338-0553-18) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 1 quarter since 2024.
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
sterile injectable · 13 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months)
For scale: the typical drug’s chance is about 0.1% — this one is 10× that.
Backtested statistical model over the whole market, not this package alone. Model details →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Baxter Healthcare Corporation | SODIUM CHLORIDE 450 mg/100mL | Jul 15, 2026 | Sep 3, 2026 |
| Baxter Healthcare Corporation | SODIUM CHLORIDE 450 mg/50mL | Jul 15, 2026 | Sep 3, 2026 |
| Baxter Healthcare Corporation | SODIUM CHLORIDE 900 mg/100mL | Jul 15, 2026 | Sep 3, 2026 |
| B. Braun Medical Inc. | SODIUM CHLORIDE 9 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Cardinal Health 107, LLC | SODIUM CHLORIDE 9 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Medical Care de Mexico, S.A. de C.V. | SODIUM CHLORIDE 900 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Medical Care Renal Therapies Group, LLC | SODIUM CHLORIDE 900 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Henry Schein, Inc. | SODIUM CHLORIDE 9 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Liebel-Flarsheim Company LLC | SODIUM CHLORIDE .9 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Nephron Pharmaceuticals Corporation | SODIUM CHLORIDE 9 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sanofi Vaccines US Inc. | SODIUM CHLORIDE 4.5 mg/.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | SODIUM CHLORIDE 9 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| Hikma Pharmaceuticals USA Inc. | SODIUM CHLORIDE 9 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Sodium Chloride — NDC 46163-0300-10," retrieved September 3, 2026, https://drugdashboards.com/drug/46163030010.
Free to cite with attribution — see how the data is put together.